Product Program year 2025 Source: CMS Open Payments

Venous Wallstent

Device Venous Wallstent_Pi

PDI 08714729979401

Open in the dashboard

General payments

$65,077

225 payments

Research payments

$0

0 payments

Through program year 2025, $65,077 in general payments and $0 in research payments were reported against Venous Wallstent (Venous Wallstent_Pi).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $5,516 14
2024 General $686 32
2023 General $12,940 52
2022 General $24,886 114
2021 General $21,050 13

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $65,077 225 payments
Top recipients General payments · program year 2025
  1. Eric Trestman Vascular Surgery · Humble, TX $5,039 91% · 4 payments
  2. Francisco Dieguez Interventional Cardiology · Hialeah, FL $138 2% · 1 payment
  3. Jorge Sarmiento Diagnostic Radiology · El Paso, TX $89 2% · 1 payment
  4. Hunter Ray Vascular Surgery · Humble, TX $89 2% · 1 payment
  5. Erin Murphy Vascular Surgery · Charlotte, NC $55 <1% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $5,183 94% · 3 practitioners
  2. Interventional Cardiology Internal Medicine $152 3% · 2 practitioners
  3. Diagnostic Radiology Radiology $89 2% · 1 practitioner
  4. Physician Assistant, Medical Physician Assistant $39 <1% · 1 practitioner
  5. Vascular & Interventional Radiology Radiology $26 <1% · 2 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $5,271 96% · 5 recipients
  2. Florida $149 3% · 2 recipients
  3. North Carolina $55 <1% · 1 recipient
  4. Tennessee $28 <1% · 2 recipients
  5. Georgia $13 <1% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

225 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record